Home › Kanser ng Endometrium
Pag-aaral pangklinika para sa Kanser ng Endometrium na nagre-recruit sa U.S.
171 pag-aaral para sa Kanser ng Endometrium ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Houston, TX69 pag-aaral
- New York City, NY54 pag-aaral
- Boston, MA51 pag-aaral
- Arlington, VA41 pag-aaral
- Nashville, TN38 pag-aaral
- Los Angeles, CA35 pag-aaral
- St. Louis, MO29 pag-aaral
- Philadelphia, PA29 pag-aaral
- Oklahoma City, OK28 pag-aaral
- San Antonio, TX27 pag-aaral
- Queens, NY26 pag-aaral
- Dallas, TX25 pag-aaral
- Pittsburgh, PA24 pag-aaral
- Columbus, OH24 pag-aaral
- Portland, OR24 pag-aaral
- Detroit, MI23 pag-aaral
- Chicago, IL23 pag-aaral
- Edison, NJ20 pag-aaral
- Minneapolis, MN20 pag-aaral
- Orlando, FL20 pag-aaral
- Washington, DC20 pag-aaral
- Rochester, MN19 pag-aaral
- Cleveland, OH19 pag-aaral
- Durham, NC19 pag-aaral
- Grand Rapids, MI18 pag-aaral
- Seattle, WA18 pag-aaral
- Baldwin Park, CA17 pag-aaral
- Atlanta, GA17 pag-aaral
- Birmingham, AL16 pag-aaral
- San Francisco, CA16 pag-aaral
- Miami, FL16 pag-aaral
- Aurora, CO16 pag-aaral
- Tampa, FL15 pag-aaral
- Austin, TX15 pag-aaral
- Denver, CO15 pag-aaral
- Charlottesville, VA15 pag-aaral
- Salt Lake City, UT15 pag-aaral
- New Haven, CT15 pag-aaral
- San Diego, CA15 pag-aaral
- Providence, RI14 pag-aaral
Ayos sa estado
- Alabama19 pag-aaral
- Alaska4 pag-aaral
- Arizona22 pag-aaral
- Arkansas11 pag-aaral
- California73 pag-aaral
- Colorado32 pag-aaral
- Connecticut22 pag-aaral
- Delaware4 pag-aaral
- District of Columbia12 pag-aaral
- Florida63 pag-aaral
- Georgia24 pag-aaral
- Hawaii3 pag-aaral
- Idaho4 pag-aaral
- Illinois35 pag-aaral
- Indiana17 pag-aaral
- Iowa10 pag-aaral
- Kansas5 pag-aaral
- Kentucky10 pag-aaral
- Louisiana14 pag-aaral
- Maine6 pag-aaral
- Maryland22 pag-aaral
- Massachusetts54 pag-aaral
- Michigan45 pag-aaral
- Minnesota42 pag-aaral
- Mississippi5 pag-aaral
- Missouri31 pag-aaral
- Montana5 pag-aaral
- Nebraska10 pag-aaral
- Nevada10 pag-aaral
- New Jersey32 pag-aaral
- New Mexico13 pag-aaral
- New York69 pag-aaral
- North Carolina34 pag-aaral
- North Dakota6 pag-aaral
- Ohio49 pag-aaral
- Oklahoma30 pag-aaral
- Oregon27 pag-aaral
- Pennsylvania46 pag-aaral
- Rhode Island14 pag-aaral
- South Carolina9 pag-aaral
- South Dakota11 pag-aaral
- Tennessee40 pag-aaral
- Texas95 pag-aaral
- Utah26 pag-aaral
- Virginia57 pag-aaral
- Washington24 pag-aaral
- West Virginia4 pag-aaral
- Wisconsin24 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
DT2216 + Paclitaxel in Platinum-Resistant Ovarian Cancer
Nagre-recruitPhase 1
Edad 18 pataas · Kababaihan · Na-update Nob 13, 2026 · NCT06964009Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Nagre-recruitPhase 2
Edad 18 pataas · Kababaihan · Na-update Nob 12, 2026 · NCT05112601A Study to Evaluate OPB-201 in Recurrent Endometrial and Platinum-resistant Ovarian Cancer.
Nagre-recruitPhase 1
Edad 18 pataas · Kababaihan · Na-update Nob 12, 2026 · NCT07664735A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06270706A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
Nagre-recruitPhase 1
Edad 16 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07197554Study of Pelvic Hypofractionated Radiotherapy in Endometrial Cancer
Nagre-recruitPhase 1/2
Edad 18 pataas · Kababaihan · Na-update Nob 12, 2026 · NCT04683653Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
Nagre-recruitPhase 2
Edad 18 hanggang 72 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT01174121Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer
Nagre-recruitPhase 1
Edad 18 pataas · Kababaihan · Na-update Nob 12, 2026 · NCT05950464A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07458347Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Nagre-recruitPhase 2
Lahat ng edad · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT05564377Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
Nagre-recruitPhase 2
Edad 18 pataas · Kababaihan · Na-update Nob 12, 2026 · NCT05640999A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
Nagre-recruitPhase 3
Edad 18 pataas · Kababaihan · Na-update Nob 10, 2026 · NCT06340568A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT07020221A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Nagre-recruitPhase 3
Edad 18 pataas · Kababaihan · Na-update Nob 10, 2026 · NCT06952504A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT07503808A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT06515613Improving Rural Endometrial Cancer Care
Nagre-recruit
Edad 18 pataas · Kababaihan · Na-update Nob 10, 2026 · NCT07927244Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Nagre-recruitPhase 3
Edad 18 pataas · Kababaihan · Na-update Nob 6, 2026 · NCT07198074A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Nagre-recruitPhase 1
Edad 19 pataas · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT06586957Assessing Survival Outcomes With Checkpoint Inhibition ExteNded vs Discontinued in Endometrial Cancer
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07867002Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial Cancer
Nagre-recruitPhase 1/2
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT06253494Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Kababaihan · Na-update Nob 5, 2026 · NCT05051722cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 40 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT05366881Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT05579366A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT06400472Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.